ArticleBMC pulmonary medicine2025
Clinical characteristics of active tuberculosis with pulmonary thromboembolism.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Pulmonary Embolism Complicating Active Pulmonary Tuberculosis: Two Case Reports of Tuberculosis-Associated Hypercoagulability.Diagnostics (Basel, Switzerland) · 2026Article
- Hypercoagulability in Pulmonary Tuberculosis: Reduced Protein C and Free Protein S Predict Pulmonary Embolism-Evidence from a Prospective Romanian Cohort.Journal of clinical medicine · 2026Article
- A case description of multisystem tuberculosis complicated with diabetes mellitus and pulmonary embolism.Quantitative imaging in medicine and surgery · 2026Article
- Pulmonary thromboembolism as an atypical manifestation of mixed connective tissue disease in a young man: A case report.The Journal of international medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn this study, we summarized clinical characteristics in patients with active tuberculosis (ATB) complicated by pulmonary thromboembolism (PTE), to further determine the influencing factors of PTE in ATB patients.
methodsThe study population consisted of ATB patients who were first seen and hospitalized from January 2014 to January 2022 in Haihe Hospital. The diagnosis of PTE was confirmed by computed tomography pulmonary angiography (CTPA), and the ATB patients were divided into a test group with PTE and a control group without PTE in this study. The Padua score is a guideline-recommended validated tool for venous thromboembolism (VTE) risk assessment in medical patients. The two groups were retrospectively compared and analyzed by clinical characteristics, including gender, age, Padua score, clinical symptoms, tuberculosis (TB) classification, routine blood tests, coagulation indexes, inflammatory indexes, imaging manifestations, and rifampicin application, etc.
resultsThere are 43 patients diagnosed with ATB complicated by PTE in this study, including 27 males (62.8%) and 16 females (37.2%), with a ratio of 1.69. Compared with the control group, test group showed higher Padua score, more frequent chest tightness and dyspnea, higher D-dimer, but with lower arterial partial pressure of carbon dioxide. Pathologically, more lobes in the test group patients had pulmonary lesions, with higher occurance in the lower and middle lobes, more image manifestations of pulmonary infarction and atelectasis. Lastly, CTPA traits showed that peripheral types are more than central types in the test group.
conclusionsATB patients should be alert to the occurrence of PTE and consider initiating anticoagulant therapy, if they have anemia, hypoproteinemia, increased D-dimer, increased inflammatory indicators, serious imaging, more pulmonary lobe involvement and lower lobe involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.